This module introduces key concepts in pharmacology. It defines terms like pharmacodynamics and pharmacokinetics. It discusses the history of pharmacology from early herbal medicines to modern drug development. It also outlines the stages of new drug development, including discovery, testing, FDA review, and post-market monitoring. The module describes the FDA's role in medication safety, including developing warnings, evaluating effectiveness, and removing drugs if needed. It explains the FDA's new pregnancy drug labeling system and provides information on the DEA's controlled substance schedules. The overall goal is for students to understand basic pharmacology terminology and processes.
This module introduces key concepts in pharmacology. It defines terms like pharmacodynamics and pharmacokinetics. It discusses the history of pharmacology from early herbal medicines to modern drug development. It also outlines the stages of new drug development, including discovery, testing, FDA review, and post-market monitoring. The module describes the FDA's role in medication safety, including developing warnings, evaluating effectiveness, and removing drugs if needed. It explains the FDA's new pregnancy drug labeling system and provides information on the DEA's controlled substance schedules. The overall goal is for students to understand basic pharmacology terminology and processes.
This module introduces key concepts in pharmacology. It defines terms like pharmacodynamics and pharmacokinetics. It discusses the history of pharmacology from early herbal medicines to modern drug development. It also outlines the stages of new drug development, including discovery, testing, FDA review, and post-market monitoring. The module describes the FDA's role in medication safety, including developing warnings, evaluating effectiveness, and removing drugs if needed. It explains the FDA's new pregnancy drug labeling system and provides information on the DEA's controlled substance schedules. The overall goal is for students to understand basic pharmacology terminology and processes.
This module introduces key concepts in pharmacology. It defines terms like pharmacodynamics and pharmacokinetics. It discusses the history of pharmacology from early herbal medicines to modern drug development. It also outlines the stages of new drug development, including discovery, testing, FDA review, and post-market monitoring. The module describes the FDA's role in medication safety, including developing warnings, evaluating effectiveness, and removing drugs if needed. It explains the FDA's new pregnancy drug labeling system and provides information on the DEA's controlled substance schedules. The overall goal is for students to understand basic pharmacology terminology and processes.
Pathophysiological Connection 2019 OER: Module 1: Introduction to Pharmacology and its Basic Concepts Objectives for Module One
Identify the definition of terms related to pharmacology
Identifythe history of pharmacology and its application to the present. Identify the stages of new drug development Identifythe role of the FDA and its impact on drug regulations Identify the new June 2015 FDA pregnancy regulations Identify the current drug schedules and give examples Definition of Terms and Brief History Pharmacology is the study of drugs. This name is from the Greek language pharmakon (drugs) and logos (study). Brief History: Experimenting with herbals, clinical practitioners work from the Chinese, Indian, and Peruvian cultures. In 1785 experimentation began with the purple foxglove plant which brought forth many years later, the drug digoxin (discussed in Module 11. Nineteenth century brought about introduction of more current pharmacology when chemists started working with morphine and cocaine even experimenting on themselves. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885127/ Still towards the end of the 19th century, John Jacob Abel founded the first pharmacology department at the University of Michigan! Go Blue! http://id.loc.gov/authorities/names/n82108754 Some of our drugs still come from plants/trees but more are prepared using recombinant DNA technology. If you want to read more about this you can access this article: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178364/ More Terms to Know
Pharmacogenomics: study of how a person’s genes affect their response to
drugs. Currently there are pharmacies which synchronize medication according to a person’s DNA but this is very expensive and the person must assume the cost. Ifyou want to read more about this please go to: https://ghr.nlm.nih.gov/primer/genomicresearch/pharmacogenomics Pharmacodynamics: the study of a drug’s response at the cell’s receptor site and the mechanism of action. Some drugs do not affect cell receptors such as antacids which increase the gastric pH for several hours and antiseptics such as alcohol wipes. These are simple chemical reactions. We will learn the terms in a little more detail in Module 3. Kipta, M. (2011). Pharmacology 101 (1st ed.). Open Educational Resources. More Terms to Know Continued Pharmacokinetics is the study of how drugs move throughout the body. How is the drug absorbed? This depends on the route such as the oral route where drugs are affected by the acidity of the stomach and the processing by the liver. Another aspect of pharmacokinetics is how drugs are distributed. This depends on the blood flow of the tissues. Then we will discuss how the drug is metabolized usually through the liver. Finally how is the drug excreted which is usually through the kidneys. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/ph armacokinetics We will learn the terms in a little more detail in Module 3. Stages of How a New Drug is Developed
StepOne is Discovery and Development: Research for a new drug
begins in the laboratory. StepTwo is Preclinical Research: drugs undergo animal and laboratory testing to answer safety questions (see pic). StepThree is Clinical Research: drugs are tested on specific groups of people (those with a health issue) to see if they respond. StepFour is Food & Drug Administration (FDA) Review: all the previous steps are reviewed prior to approval or denial Step Five is FDA Post-Market Safety Monitoring: The drug is released to the public and the FDA reviews any calls or concerns. Read by copying/pasting this link: https://www.fda.gov/drugs/ guidancecomplianceregulatoryinformation /surveillance/ucm090385.htm FDA’s Role in Medication Safety Management Assess the drug’s benefits versus the risk to the patient. They do this by putting warning labels on drugs or “black box” warnings in online software such as Micromedex. Developed tools such as package inserts to decrease the risks and educate the person or caregiver about the drug. Evaluate the effectiveness of the warnings and package inserts. Make adjustments based on results from the Post-marketing Safety Monitoring and might remove a drug from the market. Here is a link to the last 40 years of the history of the FDA and its Risk Management There is only 1 page to read and please copy/paste this link. https://www.fda.gov/drugs/risk-evaluation-and-mitigation-strategies-rems/ fdas-role-managing-medication-risks FDA’s Old/New Ruling on Labeling Drugs for Pregnancy and Lactation
The old ruling labeled all drugs developed before
2015 as Category A, B, C, D, and X: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083 079/ What does this mean for male/female patients in their reproductive years or those lactating females? Individualizedcounseling between the healthcare provider and the patient about the risks versus the benefits based on research. Lookat Table 2 in the above link to see the comparison of changes. Controlled Substance Schedules from the Drug Enforcement Agency Asof 2018 here is the link to the current drugs for Schedule I through Schedule V: https://www.deadiversion.usdoj.gov/21cfr/cfr/2108cfrt.htm Schedule I drug has no current medical use in the United States such as peyote, heroin, marihuana, and 3,4-methylenedioxymethamphetamine which is Ecstasy. Schedule II drug has a high potential for abuse which could lead to physical/psychosocial abuse such as hydromorphone, oxycodone, and fentanyl Schedule III drug has less potential for abuse then Schedule I or II physically but can still cause a risk for high psychological abuse such as Tylenol with Codeine. ScheduleIV drug has a lower potential for abuse than Schedule III such as lorazepam. ScheduleV drug has an even lower potential for abuse then Schedule IV such as cough syrups like Robitussin with Codeine. Learning Outcomes You Should Be Able to: Define/explain the terms listed in Module I such as pharmacodynamics. Briefly describe the history of pharmacology Identify the FDA’s Stages of New Drug Development Identify and briefly describe the FDA’s Role in Medication Risk Management including the last 40 years of their history Identify the FDA’s Pregnancy and Lactation Rule Identify and give an example of the DEA’s Controlled Substance Schedules I through Schedule V